Dr. Oliver Dorigo

Dr. Oliver Dorigo, MD, PhD, is a renowned gynecologic oncologist specializing in the treatment of advanced and recurrent gynecologic cancers. He serves as Director of the Division of Gynecologic Oncology at Stanford Cancer Institute and is a Professor of Obstetrics and Gynecology at the Stanford University School of Medicine. Dr. Dorigo earned both his medical degree and PhD in molecular biology from the University of Heidelberg in Germany. He completed his residency in obstetrics and gynecology at UCLA, followed by a fellowship in gynecologic oncology at the UCLA Jonsson Comprehensive Cancer Center.

Dr. Dorigo is internationally recognized for his clinical and research expertise in ovarian, endometrial, and cervical cancers. His work focuses on integrating immunotherapy and targeted therapies into standard treatment regimens, particularly for patients with chemoresistant or recurrent disease. He leads numerous clinical trials investigating novel therapeutics and has published extensively in peer-reviewed journals on cancer immunology, tumor microenvironment, and translational science. His laboratory is actively involved in developing innovative strategies to enhance immune response against gynecologic tumors.

Beyond his scientific and clinical contributions, Dr. Dorigo is a dedicated educator and mentor, guiding residents and fellows through Stanford’s academic and clinical training programs. He is known for his collaborative, multidisciplinary approach to patient care and for fostering innovation at the intersection of surgery, medical oncology, and translational research. Through his leadership in clinical trials, immunotherapy research, and academic mentorship, Dr. Dorigo continues to advance the field of gynecologic oncology and improve care for patients facing complex cancers.